Cardax Appoints Gilbert Shin as VP, Retail Sales and Marketing
December 07, 2017 at 01:00 pm
Share
Cardax, Inc. announced that Gilbert Shin has joined as Vice President, Retail Sales and Marketing, a new position for the Company. Shin will lead the company's recently announced national rollout of ZanthoSyn to the more than 3,000 corporate stores across the U.S. owned and operated by GNC Holdings, Inc. Mr. Shin most recently served as the Regional Sales Director for GNC in Hawaii. In his nearly 20-year career at GNC, Shin built Hawaii into the top performing GNC region in the country.
Cardax, Inc. is a consumer health company focused on marketing ZanthoSyn, an astaxanthin dietary supplement for inflammatory health. It seeks to monetize CDX-101, the Company's pre-clinical pharmaceutical candidate for cardiovascular inflammation and dyslipidemia, and CDX-301, the Company's pre-clinical pharmaceutical candidate for macular degeneration. CDX-101 is a proprietary astaxanthin prodrug that cleaves following oral administration and delivers astaxanthin to the bloodstream. Astaxanthin is a naturally occurring molecule with safe anti-inflammatory activity that supports cardiovascular health, metabolic health, liver health, joint health, and longevity. It intends to develop zeaxanthin pharmaceutical candidate, CDX-301, for macular degeneration. Zeaxanthin accumulates in the human eye through uptake by a retinal receptor, providing protection against blue light, oxidative damage, and related inflammation that occurs in macular degeneration.
CARDAX, INC. 
